Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Monsanto Co. -- Ignore unavailable to you. Want to Upgrade?

To: Dan Spillane who wrote (672)	12/1/1998 4:17:00 PM
From: jopawa	Read Replies (1) \| Respond to of 2539

Dan, Probably no big black helicopter one world order conspiracy from Reuters<gg>, just beat to the punch by Bloomberg. Here's Reuters take on it. John Tuesday December 1, 2:13 pm Eastern Time U.S. FDA panel backs Searle drug for arthritis SILVER SPRING, Md., Dec 1 (Reuters) - A U.S. Food and Drug Administration advisory panel voted on Tuesday to recommend that G.D. Searle's Celebrex be approved for treating the pain of osteoarthritis and rheumatoid arthritis. The panel was still discussing whether the drug should carry a label warning of safety considerations and whether to approve it for managing pain such as that suffered after an operation. The drug would be the first on the U.S. market in a new class known as COX-2 inhibitors. They are designed to work as well as other analgesics such as aspirin, ibuprofen and naproxen but without potentially fatal side effects. Analysts say the market is huge, with potential sales of $1 billion in the first year in the United States alone if Celebrex is launched next year as the company hopes. The FDA has expedited consideration of the drug and usually acts on the advice of its panels. Rheumatoid arthritis is an auto-immune disease caused when the body's immune system mistakenly turns against the joints. Osteoarthritis is the ''wear and tear'' form of arthritis. Both cause painful and swollen joints. Patients must often take drugs for years because neither disease has a cure, so safer drugs are highly desirable. Searle is a unit of Monsanto Corp. (NYSE:MTC - news).